Cargando…

Host or pathogen-related factors in COVID-19 severity?

Detalles Bibliográficos
Autores principales:	Gortázar, Christian, del-Río, Francisco J Rodríguez, Domínguez, Lucas, de la Fuente, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598310/ https://www.ncbi.nlm.nih.gov/pubmed/33129391 http://dx.doi.org/10.1016/S0140-6736(20)32215-7

Ejemplares similares

Host or pathogen-related factors in COVID-19 severity? – Authors' reply
por: Okell, Lucy C, et al.
Publicado: (2020)

Wild Boars as Hosts of Human-Pathogenic Anaplasma phagocytophilum Variants
por: de la Fuente, José, et al.
Publicado: (2012)

COVID-19 epidemiology and rural healthcare: a survey in a Spanish village
por: Rodríguez-del-Río, Francisco J., et al.
Publicado: (2023)

COVID-19 is likely to impact animal health
por: Gortázar, Christian, et al.
Publicado: (2020)

Will we ever eradicate animal tuberculosis?
por: Gortázar, Christian, et al.
Publicado: (2023)

The sound of host-SARS-CoV-2 molecular interactions
por: de la Fuente, José, et al.
Publicado: (2021)

Correlates with Vaccine Protective Capacity and COVID-19 Disease Symptoms Identified by Serum Proteomics in Vaccinated Individuals
por: Villar, Margarita, et al.
Publicado: (2022)

Host Richness Increases Tuberculosis Disease Risk in Game-Managed Areas
por: Barasona, Jose Angel, et al.
Publicado: (2019)

Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology
por: Villar, Margarita, et al.
Publicado: (2021)

Evidence of the Importance of Host Habitat Use in Predicting the Dilution Effect of Wild Boar for Deer Exposure to Anaplasma spp
por: Estrada-Peña, Agustín, et al.
Publicado: (2008)

Immunity to glycan α-Gal and possibilities for the control of COVID-19
por: de la Fuente, José, et al.
Publicado: (2020)

Intrapulmonary Bronchopulmonary Anastomoses in Severe COVID-19–related Acute Respiratory Failure
por: Bodmer, Jenna, et al.
Publicado: (2022)

Vaccine efficacy against COVID-19: A foresight on the host-associated factors
por: Priyanka, et al.
Publicado: (2021)

Estimating Global Epidemiology of Low-Pathogenic Human Coronaviruses in Relation to the COVID-19 Context
por: Li, Pengfei, et al.
Publicado: (2020)

Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?
por: Aguirre, Clara, et al.
Publicado: (2020)

Combining immunomodulators and antivirals for COVID-19 – Authors' reply
por: Almansa, Raquel, et al.
Publicado: (2021)

Elevated factor V activity and antigen levels in patients with Covid‐19 are related to disease severity and 30‐day mortality
por: von Meijenfeldt, Fien A., et al.
Publicado: (2021)

Analysis of Host Factor related to Patient's Mortality due to Viridans Streptococcal Bacteremia
por: Song, Soo-Kyeong, et al.
Publicado: (2013)

Editorial: Tick-Host-Pathogen Interactions
por: Bonnet, Sarah I., et al.
Publicado: (2018)

Is COVID-19 a risk factor for severe preeclampsia? Hospital experience in a developing country
por: Coronado-Arroyo, Julia Cristina, et al.
Publicado: (2021)

The impact of specific cytokine directed treatment on severe COVID-19
por: Reuken, P. A., et al.
Publicado: (2021)

Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection
por: Reuken, Philipp A., et al.
Publicado: (2021)

Response to “Incidence and severity of pediatric appendicitis during the COVID‑19 pandemic”
por: del Giorgio, Francesca, et al.
Publicado: (2023)

Plea for multitargeted interventions for severe COVID-19
por: Gaborit, Benjamin Jean, et al.
Publicado: (2020)

Zoonotic Pathogens among White-Tailed Deer, Northern Mexico, 2004–2009
por: Medrano, Citlaly, et al.
Publicado: (2012)

Need to promote healthy lifestyle as primary prevention to the COVID-19 and to improve the immune response to vaccines
por: De la Cámara, Miguel A, et al.
Publicado: (2021)

Fine-tuning the space, time, and host distribution of mycobacteria in wildlife
por: Gortazar, Christian, et al.
Publicado: (2011)

Severe COVID-19 in an Infant with Severe Acute Malnutrition
por: Beniwal, Neetu, et al.
Publicado: (2021)

Mavrilimumab for severe COVID-19
por: Khan, Adil Rashid, et al.
Publicado: (2020)

Mavrilimumab for severe COVID-19
por: Pourhoseingholi, Mohamad Amin, et al.
Publicado: (2020)

Ruxolitinib and Severe COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Hypertension and severe COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2023)

Polymorphisms and Severity of COVID-19
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Potentially fatal severe brady arrythmias related to Lopinavir-Ritonavir in a COVID 19 patient
por: Shree, Venkatesan, et al.
Publicado: (2021)

Co-infection with an atypical pathogen of COVID-19 in a young
por: Chen, Fu-Lun, et al.
Publicado: (2021)

Effectiveness of dexmedetomidine combined with high flow nasal oxygen and long periods of awake prone positioning in moderate or severe COVID-19 pneumonia
por: Taboada, Manuel, et al.
Publicado: (2021)

Akirin/Subolesin regulatory mechanisms at host/tick–pathogen interactions
por: de la Fuente, José, et al.
Publicado: (2021)

The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_26fe234gdv2nf5jukhjkjr3oi3